29 reports

  • GLOBAL RNAI TECHNOLOGY MARKET, BY REGION, 2014-2022 (IN USD MILLION)
  • NORTH AMERICAN RNAI TECHNOLOGY MARKET, 2014-2022 (IN USD MILLION)

RNAi Technology Market The market for RNAi technology is estimated to be USD 12.56 billion in 2016 and is expected to reach USD 31.52 billion by 2021, growing at a CAGR of 20.19% RNA interference (RNAi) is a natural process of treating forms of cancer and other diseases by post-transcriptional silencing of genes by small fragments...

  • RNAi Technology
  • World
  • Alnylam Pharmaceuticals, Inc.
  • Arcturus Therapeutics, Inc.
  • Sirna Therapeutics, Inc.

REASONS FOR DOING THIS STUDY The RNAi market is burgeoning and is one of the most watched markets in the pharmaceuticals industry.

  • Biological Therapy
  • RNAi Technology
  • World
  • Market Shares
  • Market Size

List of Tables Table ## Global RNAi Technologies Market By Region, Market Forecast (2013-2025) (US$ MN) Table ## Global RNAi Technologies Market By Application, Market Forecast (2013-2025) (US$ MN) Table ## Global RNAi Technologies Market B

  • RNAi Technology
  • APAC
  • World
  • Forecast
  • Market Size
  • Benitec Biopharma Ltd, Major Products and Services
  • Benitec Biopharma Ltd - Major Products and Services

Benitec Biopharma Ltd (BLT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats....

  • Biopharmaceutical
  • Hepatitis
  • RNAi Technology
  • Therapy
  • Benitec Biopharma Limited
  • OTHER LOCATIONS & SUBSIDIARIES

We are highly committed and motivated by the potential of RNAi based therapies using our GalNAc-siRNA technology.

  • Pharmaceutical
  • RNAi Technology
  • Therapy
  • United Kingdom
  • Silence Therapeutics
  • DEAL TYPE
  • DEAL TYPE

The therapy is based on DNA-directed RNA interference (ddRNAi) technology.

  • Biopharmaceutical
  • Healthcare
  • RNAi Technology
  • Therapy
  • Benitec Biopharma Limited
  • LICENSING AGREEMENTS
  • FEB 07, 2017: RXI PHARMACEUTICALS APPOINTS LEADING ONCOLOGY EXPERT, DR. ROLF KIESSLING, TO SCIENTIFIC ADVISORY BOARD

" RXi Pharmaceuticals' self-delivering RNAi (sd-rxRNA) technology is one of the most innovative developments in the space, " said Dr.

  • Healthcare
  • Pharmaceutical
  • RNAi Technology
  • United States
  • RXi Pharmaceuticals Corporation
  • Proliferative Vitreoretinopathy (PVR) - Drug Profiles

The company uses RNAi and sd-rxRNA technologies for the development of products.

  • RNAi Technology
  • Therapy
  • United States
  • Product Initiative
  • RXi Pharmaceuticals Corporation

Arcturus Therapeutics now owns the UNA technology patent estate, enabling the company to operate freely and to independently pursue RNAi therapeutics.

  • Pharmaceutical
  • RNAi Technology
  • Therapy
  • United States
  • Arcturus Therapeutics, Inc.

Agrow: RNAi

2709 2980 2303

It details company and product profiles, and activities and pipelines of specialist companies and research institutes engaged in RNAi technology.

  • Biological Therapy
  • RNA Interference
  • RNAi Technology
  • United States
  • Litigation And Patent
  • ALNYLAM PHARMA ENTERS INTO LICENSING AGREEMENT WITH ASCLETIS PHARMA (HANGZHOU) TO DEVELOP ALN-VSP
  • ALNYLAM PHARMA AND GENZYME ENTER INTO AGREEMENT FOR RNAI THERAPEUTICS AS GENETIC MEDICINES

The drug candidate is developed based on RNAi Technology and LNP technology.

  • Pharmaceutical
  • RNA Interference
  • RNAi Technology
  • Therapy
  • Alnylam Pharmaceuticals, Inc.

Arcturus Therapeutics owns the UNA technology patent estate, enabling Marina Biotech to operate freely and to independently pursue RNAi therapeutics.

  • Biotech
  • RNAi Technology
  • United States
  • Company
  • Marina Biotech, Inc.

About Dicer Substrate Technology Dicerna' s proprietary RNAi molecules are known as Dicer substrates, or DsiRNAs, so called because they are processed by the Dicer enzyme, which is the initiation point for RNAi in the human cell cytoplasm.

  • Biotech
  • RNAi Technology
  • World
  • Product Initiative
  • Marina Biotech, Inc.

The company offers product through its technology platform, RNA interference.

  • Pharmaceutical
  • RNAi Technology
  • United States
  • Corporate Finance
  • RXi Pharmaceuticals Corporation

The company offers product through its technology platform, RNA interference.

  • Pharmaceutical
  • RNAi Technology
  • United States
  • Corporate Finance
  • RXi Pharmaceuticals Corporation

Under the agreement, Dicerna Pharma has obtained license to Tekmira Pharma' s proprietary lipid nanoparticle (LNP) delivery technology for exclusive use in Dicerna Pharma' s primary hyperoxaluria type ## (PH##) development program.

  • Healthcare
  • Pharmaceutical
  • RNAi Technology
  • Therapy
  • Dicerna Pharmaceuticals, Inc.

No Development Reported in Cancer Drugs in Clinical Pipeline ##. ## RNA Interference-Based Technology – Alnylam ##. ## RNAi Therapeutics - Alnylam/ University of California San Francisco ##.

  • Biological Therapy
  • Pharmaceutical
  • RNAi Technology
  • Therapy
  • United States
  • RNAI OLIGONUCLEOTIDES FOR NASH, CARDIOVASCULAR AND METABOLIC DISORDERS
  • RNAI OLIGONUCLEOTIDES FOR GENETIC DISEASES

Alnylam Pharmaceuticals, Inc. - Product Pipeline Review - 2016 Summary Global Markets Direct’s, ‘Alnylam Pharmaceuticals, Inc. - Product Pipeline Review, 2016’, provides an overview of the Alnylam Pharmaceuticals, Inc.’s pharmaceutical research and development focus. The report provides comprehensive information...

  • Pharmaceutical
  • Research And Development
  • RNAi Technology
  • Therapy
  • Alnylam Pharmaceuticals, Inc.

This grant will be used for the development of Single Strand RNAi Technology Platform.

  • RNAi Technology
  • United States
  • Corporate Finance
  • M&A
  • Alnylam Pharmaceuticals, Inc.

Roche will use Tekmira' s SNALP technology for two RNAi product candidates.

  • Biopharmaceutical
  • Pharmaceutical
  • RNAi Technology
  • Therapy
  • Arbutus Biopharma Corporation
  • Key Information
  • Product Description

Benitec Biopharma Limited - Product Pipeline Review - 2015 Summary Global Markets Direct’s, ‘Benitec Biopharma Limited - Product Pipeline Review - 2015’, provides an overview of the Benitec Biopharma Limited’s pharmaceutical research and development focus. This report provides comprehensive information on the current...

  • Biopharmaceutical
  • Hepatitis
  • RNAi Technology
  • Therapy
  • Benitec Biopharma Limited
  • STP-703
  • STP-911

Sirnaomics, Inc. - Product Pipeline Review - 2016 Summary Global Markets Direct’s, ‘Sirnaomics, Inc. - Product Pipeline Review - 2016’, provides an overview of the Sirnaomics, Inc.’s pharmaceutical research and development focus. The report provides comprehensive information on the therapeutics under development...

  • RNAi Technology
  • China
  • United States
  • Company Operations
  • Sirnaomics, Inc.

RNAi for Therapeutic Applications: Technology and Market Forecast 2015-2025: Prospects for siRNAs, shRNAs and ddRNAi Approaches Table of Contents ##.

  • Biological Therapy
  • RNA Interference
  • RNAi Technology
  • World
  • Market Size

Roche will use Tekmira' s SNALP technology for two RNAi product candidates.

  • RNAi Technology
  • United States
  • Company
  • Corporate Finance
  • Tekmira Pharmaceuticals Corporation
  • RXI PHARMACEUTICALS CORPORATION - DRUG PROFILES

The drug therapy is developed on RNA interference (RNAi) technology.

  • RNA Interference
  • RNAi Technology
  • United States
  • Company Operations
  • RXi Pharmaceuticals Corporation

The novel acquired technologies potentially enable in-vivo delivery of RNAi therapeutics.

  • Pharmaceutical
  • RNAi Technology
  • United States
  • Corporate Finance
  • Galena Biopharma, Inc.

It uses RNAi and sd-rxRNA technologies for the development of products.

  • Research And Development
  • RNAi Technology
  • United States
  • Company Operations
  • RXi Pharmaceuticals Corporation

## RNAI AS THERAPY ## THE PROMISE OF RNAI ## TABLE ## VARIOUS TECHNOLOGIES FOR GENE SUPPRESSION ## RNAI TECHNOLOGY ## RNAI MECHANISM: HOW DOES IT WORK?

  • Biological Therapy
  • RNAi
  • RNAi Technology
  • World
  • Forecast

Global RNA Interference (RNAi) Therapy Market Outlook 2018 ##.

  • Biological Therapy
  • RNA Interference
  • RNAi
  • RNAi Technology
  • World